Cargando…
An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India
BACKGROUND: The bivalent killed oral cholera vaccine (OCV) provides 65% cumulative protection over five years. It remains unknown whether a boosting regimen can maintain protection in previously immunized populations. This study examines the immunogenicity and safety of an OCV regimen given five yea...
Autores principales: | Kanungo, Suman, Desai, Sachin N., Saha, Jayanta, Nandy, Ranjan Kumar, Sinha, Anuradha, Kim, Deok Ryun, Bannerjee, Barnali, Manna, Byomkesh, Yang, Jae Seung, Ali, Mohammad, Sur, Dipika, Wierzba, Thomas F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449043/ https://www.ncbi.nlm.nih.gov/pubmed/26023778 http://dx.doi.org/10.1371/journal.pntd.0003809 |
Ejemplares similares
-
Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India
por: Kanungo, Suman, et al.
Publicado: (2014) -
Tetracycline-Resistant Vibrio cholerae O1, Kolkata, India
por: Bhattacharya, Koel, et al.
Publicado: (2011) -
Trials and tribulations of conducting interventional studies in urban slums of a developing country: Experiences from Kolkata, India
por: Mahapatra, Tanmay, et al.
Publicado: (2015) -
A Randomized, Placebo-Controlled Trial of the Bivalent Killed, Whole-Cell, Oral Cholera Vaccine in Adults and Children in a Cholera Endemic Area in Kolkata, India
por: Mahalanabis, Dilip, et al.
Publicado: (2008) -
Flexibility of Oral Cholera Vaccine Dosing—A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone
por: Kanungo, Suman, et al.
Publicado: (2015)